Hair Up Laser designs and develops a medical device that uses photobiomodulation to curb the effects of androgenic alopecia, the most common form of hair loss in both men and women. The company positions its technology as a non-invasive alternative aimed at restoring patients’ hair and self-esteem, with particular emphasis on the emotional impact of alopecia on women. Fresh capital will finance a clinical trial at Hospital Sant Pau in Barcelona and complete regulatory work to meet European medical-device standards. The trial already has ethics-committee approval and is awaiting authorization from the Spanish Agency of Medicines and Medical Devices, with completion targeted for the first half of 2026. Upon successful trials, Hair Up Laser intends to secure CE marking and launch the device across Europe. The startup operates in a global hair-loss treatment market estimated at $10 billion annually, where 2.2 million people seek surgical or non-surgical solutions each year. The recent €880 k fundraise combines private investment and public support to advance the company toward commercialization.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2025